Resona Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.49M Sell
110,318
-13,713
-11% -$914K 0.04% 392
2026
Q1
$7.77M Buy
124,031
+1,448
+1% +$101K 0.04% 387
2025
Q4
$8.16M Sell
122,583
-7,205
-6% -$466K 0.04% 372
2025
Q3
$8.71M Sell
129,788
-7,504
-5% -$594K 0.04% 364
2025
Q2
$12M Buy
137,292
+11,139
+9% +$873K 0.06% 298
2025
Q1
$8.6M Buy
126,153
+4,667
+4% +$381K 0.05% 332
2024
Q4
$9.49M Sell
121,486
-6,976
-5% -$516K 0.06% 305
2024
Q3
$8.62M Buy
128,462
+5,101
+4% +$419K 0.05% 332
2024
Q2
$14M Sell
123,361
-8,105
-6% -$1.02M 0.08% 216
2024
Q1
$18.2M Buy
+131,466
New +$16.5M 0.11% 186

Other funds holding DXCM

Resona Asset Management's DXCM Position: Q2 2026 in Review

Resona Asset Management reduced its DexCom (DXCM) stake by 11% in Q2 2026, selling an estimated $914K and leaving 110,318 shares worth $7.49M. The position accounts for 0.04% of the portfolio, ranked #392.

Resona Asset Management first reported a position in DXCM in Q1 2024 and has held it in 10 quarters since. The position peaked at $18.2M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Resona Asset Management held 110,318 shares of DexCom worth $7.49M as of Q2 2026.
  • Resona Asset Management sold 13,713 DexCom shares in Q2 2026, an estimated $914K.
  • DexCom made up 0.04% of Resona Asset Management's portfolio in Q2 2026, its #392 holding.
  • Resona Asset Management first reported a position in DexCom in Q1 2024 and has held it in 10 quarters since.
  • Resona Asset Management's DexCom position peaked at $18.2M in Q1 2024.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.